-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Prestige Consumer Healthcare (NYSE:PBH) Price Target Cut to $63.00 by Analysts at Oppenheimer
Prestige Consumer Healthcare (NYSE:PBH) Price Target Cut to $63.00 by Analysts at Oppenheimer
Prestige Consumer Healthcare (NYSE:PBH – Get Rating) had its target price cut by Oppenheimer to $63.00 in a research note published on Thursday, Stock Target Advisor reports.
Separately, DA Davidson reaffirmed a neutral rating on shares of Prestige Consumer Healthcare in a report on Tuesday, August 9th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus target price of $80.50.
Get Prestige Consumer Healthcare alerts:Prestige Consumer Healthcare Stock Up 0.4 %
PBH opened at $50.17 on Thursday. The company has a quick ratio of 1.23, a current ratio of 2.09 and a debt-to-equity ratio of 0.93. The firm has a 50 day moving average price of $54.61 and a 200-day moving average price of $55.26. Prestige Consumer Healthcare has a twelve month low of $48.51 and a twelve month high of $63.83. The stock has a market capitalization of $2.50 billion, a price-to-earnings ratio of 12.57, a PEG ratio of 1.45 and a beta of 0.55.
Institutional Trading of Prestige Consumer Healthcare
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. M&G Investment Management Ltd. boosted its position in shares of Prestige Consumer Healthcare by 5.2% in the second quarter. M&G Investment Management Ltd. now owns 29,077 shares of the company's stock worth $1,716,000 after purchasing an additional 1,446 shares during the period. Summit Global Investments boosted its position in shares of Prestige Consumer Healthcare by 87.3% in the second quarter. Summit Global Investments now owns 48,428 shares of the company's stock worth $2,848,000 after purchasing an additional 22,566 shares during the period. Captrust Financial Advisors boosted its position in shares of Prestige Consumer Healthcare by 9.1% in the second quarter. Captrust Financial Advisors now owns 3,011 shares of the company's stock worth $177,000 after purchasing an additional 252 shares during the period. Legal & General Group Plc boosted its position in shares of Prestige Consumer Healthcare by 1.4% in the second quarter. Legal & General Group Plc now owns 144,276 shares of the company's stock worth $8,484,000 after purchasing an additional 1,926 shares during the period. Finally, Walleye Capital LLC boosted its position in shares of Prestige Consumer Healthcare by 255.2% in the second quarter. Walleye Capital LLC now owns 28,156 shares of the company's stock worth $1,656,000 after purchasing an additional 20,230 shares during the period. 99.37% of the stock is owned by hedge funds and other institutional investors.About Prestige Consumer Healthcare
(Get Rating)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Recommended Stories
- Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
- Humana Proves Vertically Integrated Healthcare Works
- This Small-Cap Healthcare Name Is Outperforming Its Index
- 2 Casino Stocks Worth Taking a Look At
- What Cintas Can Teach Investors About This Bear Market?
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
Prestige Consumer Healthcare (NYSE:PBH – Get Rating) had its target price cut by Oppenheimer to $63.00 in a research note published on Thursday, Stock Target Advisor reports.
据Stock Target Advisor报道，在周四发布的一份研究报告中，威望消费者医疗保健公司(NYSE：PBH-GET评级)的目标价被奥本海默下调至63.00美元。
Separately, DA Davidson reaffirmed a neutral rating on shares of Prestige Consumer Healthcare in a report on Tuesday, August 9th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus target price of $80.50.
另外，DA Davidson在8月9日星期二的一份报告中重申了对Prestige Consumer Healthcare股票的中性评级。两名投资分析师对该股的评级为持有，三名分析师对该公司股票的评级为买入。根据MarketBeat.com的数据，该股的平均评级为中等买入，共识目标价为80.50美元。
Prestige Consumer Healthcare Stock Up 0.4 %
威望消费者医疗保健类股上涨0.4%
PBH opened at $50.17 on Thursday. The company has a quick ratio of 1.23, a current ratio of 2.09 and a debt-to-equity ratio of 0.93. The firm has a 50 day moving average price of $54.61 and a 200-day moving average price of $55.26. Prestige Consumer Healthcare has a twelve month low of $48.51 and a twelve month high of $63.83. The stock has a market capitalization of $2.50 billion, a price-to-earnings ratio of 12.57, a PEG ratio of 1.45 and a beta of 0.55.
PBH周四开盘报50.17美元。该公司的速动比率为1.23，流动比率为2.09，债务权益比率为0.93。该公司的50日移动均线价格为54.61美元，200日移动均线价格为55.26美元。威望消费者医疗保健公司的12个月低点为48.51美元，12个月高位为63.83美元。该股市值为25亿美元，市盈率为12.57倍，聚乙二醇率为1.45倍，贝塔系数为0.55。
Institutional Trading of Prestige Consumer Healthcare
威望消费者医疗保健的机构交易
About Prestige Consumer Healthcare
关于Prestige Consumer Healthcare
(Get Rating)
(获取评级)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
威望消费者保健公司及其子公司在美国和国际上开发、制造、营销、分销和销售非处方药(OTC)健康和个人护理产品。该公司在北美OTC Healthcare和国际OTC Healthcare两个部门运营。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
- Humana Proves Vertically Integrated Healthcare Works
- This Small-Cap Healthcare Name Is Outperforming Its Index
- 2 Casino Stocks Worth Taking a Look At
- What Cintas Can Teach Investors About This Bear Market?
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
- 免费获取StockNews.com关于Prestige Consumer Healthcare(PBH)的研究报告
- Humana证明垂直整合的医疗保健工作
- 这家小盘股医疗保健公司的表现好于其指数
- 值得一看的2只赌场股票
- 关于这个熊市，Cintas能教给投资者什么？
- 黑莓股价下跌，业绩再次不温不火
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
获得《尊贵消费者保健日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Prestige Consumer Healthcare和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧